2020
• Baldeh T, Saz-Parkinson Z, Muti P, Santesso N, Morgano GP, Wiercioch W, Nieuwlaat R, Gräwingholt A, Broeders M, Duffy S, Hofvind S, Nystrom L, Ioannidou-Mouzaka L, Warman S, McGarrigle H, Knox S, Fitzpatrick P, Rossi PG, Quinn C, Borisch B, Lebeau A, de Wolf C, Langendam M, Piggott T, Giordano L, van Landsveld-Verhoeven C, Bernier J, Rabe P, Schünemann HJ. Development and use of health outcome descriptors: a guideline development case study. Health Qual Life Outcomes. 2020 Jun 5;18(1):167.
• Bick U, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PAT, Bernathova M, Borbély K, Brkljacic B, Carbonaro LA, Clauser P, Cassano E, Colin C, Esen G, Evans A, Fallenberg EM, Fuchsjaeger MH, Gilbert FJ, Helbich TH, Heywang-Köbrunner SH, Herranz M, Kinkel K, Kilburn-Toppin F, Kuhl CK, Lesaru M, Lobbes MBI, Mann RM, Martincich L, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Schiaffino S, Sella T, Thomassin-Naggara I, Tardivon A, Ongeval CV, Wallis MG, Zackrisson S, Forrai G, Herrero JC, Sardanelli F; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition. Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2020 Feb 5;11(1):12.
• Boersma LJ, Verloop J, Voogd AC, Elkhuizen PHM, Houben R, van Leeuwen AE, Linn S, de Munck L, Pijnappel R, Strobbe L, van Dalen T, Wesseling J, Poortmans P. Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03). Radiother Oncol. 2020 Apr;145:201-208.
• Boita J, Bolejko A, Zackrisson S, Wallis MG, Ikeda DM, Van Ongeval C, van Engen RE, Mackenzie A, Tingberg A, Bosmans H, Pijnappel R, Sechopoulos I, Broeders M. Development and content validity evaluation of a candidate instrument to assess image quality in digital mammography: A mixed-method study. Eur J Radiol. 2020 Dec 2;134:109464.
• Broeders M, Elfström KM. Importance of International Networking and Comparative Research in Screening to Meet the Global Challenge of Cancer Control. JCO Glob Oncol. 2020 Feb;6:180-181.
• de Munck L, Siesling S, Fracheboud J, den Heeten GJ, Broeders MJM, de Bock GH. Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands. Br J Cancer. 2020 Sep;123(7):1191-1197.
• Dinmohamed AG, Cellamare M, Visser O, de Munck L, Elferink MAG, Westenend PJ, Wesseling J, Broeders MJM, Kuipers EJ, Merkx MAW, Nagtegaal ID, Siesling S. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol. 2020 Nov 4;13(1):147.
• Lameijer JRC, Voogd AC, Pijnappel RM, Setz-Pels W, Broeders MJ, Tjan-Heijnen VCG, Duijm LEM. Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands. Br J Cancer. 2020 Jul;123(2):325-332.
• Luiten JD, Voogd AC, Luiten EJT, Broeders MJM, Roes KCB, Tjan-Heijnen VCG, Duijm LEM. Recall and Outcome of Screen-detected Microcalcifications during 2 Decades of Mammography Screening in the Netherlands National Breast Screening Program. Radiology. 2020 Mar;294(3):528-537.
• Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N, Borisch B, Castells X, Duffy SW, Fitzpatrick P, Follmann M, Giordano L, Hofvind S, Lebeau A, Quinn C, Torresin A, Vialli C, Siesling S, Ponti A, Giorgi Rossi P, Schünemann H, Nyström L, Broeders M; ECIBC contributor group. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer. 2020 Aug 24;20(1):795.
• Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, Moorthie S, De Montgolfier S, Baron C, Herceg Z, Turnbull C, Balleyguier C, Rossi PG, Wesseling J, Ritchie D, Tischkowitz M, Broeders M, Reisel D, Metspalu A, Callender T, de Koning H, Devilee P, Delaloge S, Schmidt MK, Widschwendter M. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020 Nov;17(11):687-705. Erratum in: Nat Rev Clin Oncol. 2020 Jun 29.
• Rainey L, Eriksson M, Trinh T, Czene K, Broeders MJM, van der Waal D, Hall P. The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk. Int J Cancer. 2020 Aug 15;147(4):931-939.
• Rainey L, van der Waal D, Broeders MJM. Dutch women’s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers. BMC Cancer. 2020 Oct 6;20(1):965.
• Rainey L, van der Waal D, Jervaeus A, Donnelly LS, Evans DG, Hammarström M, Hall P, Wengström Y, Broeders MJM. European women’s perceptions of the implementation and organisation of risk-based breast cancer screening andprevention: a qualitative study. BMC Cancer. 2020 Mar 24;20(1):247.
• Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, de Koning HJ, van Ravesteyn NT. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis. Radiology. 2020 Oct;297(1):40-48.
• Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, Broeders MJM, de Koning HJ. Risk stratification in breast cancer screening: Cost-effectiveness and harm- benefit ratios for lowrisk and high-risk women. Int J Cancer. 2020 Dec 1;147(11):3059-3067.
• Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Gräwingholt A, SazParkinson Z; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med. 2020 Jan 7;172(1):46-56.
• Sechopoulos I, Athanasiou A. Digital Breast Tomosynthesis Screening: Better But Still Not Good Enough for All Women. Radiology. 2020 Dec;297(3):532-533.
• Sechopoulos I, Boone JM, Dance D, van Engen R, Russo P, Young KC. Mammography dose estimates do not reflect any specific patient’s breast dose. Eur J Radiol. 2020 Oct;131:109216.
• Sechopoulos I, Mann RM. Stand-alone artificial intelligence – The future of breast cancer screening? Breast. 2020 Feb;49:254-260.
• Sechopoulos I, Teuwen J, Mann R. Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: State of the art. Semin Cancer Biol. 2020 Jun 9:S1044-579X(20)30135-8.
• van der Waal D, Bekkers RLM, Dick S, Lenselink CH, Massuger LFAG, Melchers WJG, Schmeink CE, Siebers AG, Broeders MJM. Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status. Prev Med. 2020 Jan;130:105927.
• Verburg E, van Gils CH, Bakker MF, Viergever MA, Pijnappel RM, Veldhuis WB, Gilhuijs KGA. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses. Invest Radiol. 2020 Jul;55(7):438-444.
• Wang J, Phi XA, Greuter MJW, Daszczuk AM, Feenstra TL, Pijnappel RM, Vermeulen KM, Buls N, Houssami N, Lu W, de Bock GH. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Eur Radiol. 2020 Oct;30(10):5437-5445.
• Wielema M, Dorrius MD, Pijnappel RM, De Bock GH, Baltzer PAT, Oudkerk M, Sijens PE. Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: A systematic review and meta-analysis. PLoS One. 2020 May 6;15(5):e0232856.

2019
• Aarts A, Duffy SW, Geurts S, Vulkan DP, Otten J, Hsu CY, Chen T, Verbeek A, Broeders M. Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands). J Med Screen. 2019 Sep;26(3):147-153.
• Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Houssami N, Zappa M, Nagtegaal ID, Verbeek ALM, Broeders MJM. Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. Breast. 2019 Jun;45:70-74.
• Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van’t Veer L, Wenger N, Wolfson M, Yau C, Ziv E. A response to “Personalised medicine and population health: breast and ovarian cancer”. Hum Genet. 2019 Mar;138(3):287-289.
• Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med. 2019 Nov 28;381(22):2091-2102.
• Balta C, Bouwman RW, Broeders MJM, Karssemeijer N, Veldkamp WJH, Sechopoulos I, van Engen RE. Optimization of the difference-of-Gaussian channel sets for the channelized Hotelling observer. J Med Imaging (Bellingham). 2019 Jul;6(3):035501.
• Balta C, Bouwman RW, Sechopoulos I, Broeders MJM, Karssemeijer N, van Engen RE, Veldkamp WJH. Can a channelized Hotelling observer assess image quality in acquired mammographic images of an anthropomorphic breast phantom including image processing? Med Phys. 2019 Feb;46(2):714-725.
• Caballo M, Michielsen K, Fedon C, Sechopoulos I. Towards 4D dedicated breast CT perfusion imaging of cancer: development and validation of computer simulated images. Phys Med Biol. 2019 Nov 8. doi: 10.1088/1361-6560/ab55ac. [Epub ahead of print]
• Coolen AMP, Lameijer JRC, Voogd AC, Louwman MWJ, Strobbe LJ, Tjan-Heijnen VCG, Duijm LEM. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography. Eur Radiol. 2019 Jan;29(1):337-344.
• den Dekker BM, van Diest PJ, de Waard SN, Verkooijen HM, Pijnappel RM. Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed? Eur J Radiol. 2019 Nov;120:108665.
• Dustler M, Wicklein J, Förnvik H, Boita J, Bakic P, Lång K. High-attenuation artifact reduction in breast tomosynthesis using a novel reconstruction algorithm. Eur J Radiol. 2019 Jul;116:21-26.
• Geertse TD, Paap E, van der Waal D, Duijm LEM, Pijnappel RM, Broeders MJM. Utility of Supplemental Training to Improve Radiologist Performance in Breast Cancer Screening: A Literature Review. J Am Coll Radiol. 2019 Nov;16(11):1528-1546.
• Jansen PR, Broeders MJM, Cornel MC, Meijers-Heijboer H. [Polygenic risk prediction of common diseases: from epidemiology to clinical application]. Ned Tijdschr Geneeskd. 2019 Sep 24;163. pii: D3870. Dutch.
• Keymeulen KBIM, Geurts SME, Lobbes MBI, Heuts EM, Duijm LEM, Kooreman LFS, Voogd AC, Tjan-Heijnen VCG. Population-based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2019 Oct;106(11):1488-1494.
• Kim YJ, Sechopoulos I, Newell MS, Ho CP, Holbrook AI, Fleming M, Hamlin MB, Handa P, Braykov N, D’Orsi CJ. Comparison of two-view digital breast tomosynthesis to three-view digital mammography in a simulated screening setting. Acta Radiol. 2019 Sep;60(9):1094-1101.
• Luiten JD, Korte B, Voogd AC, Vreuls W, Luiten EJT, Strobbe LJ, Rutten MJCM, Plaisier ML, Lohle PN, Hooijen MJH, Tjan-Heijnen VCG, Duijm LEM. Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study. Int J Cancer. 2019 Nov 15;145(10):2720-2727.
• Luiten JD, Voogd AC, Tjan-Heijnen VCG, Wesseling J, Luiten EJT, Duijm LEM. Utility of diagnostic breast excision biopsies during two decades of screening mammography. Breast. 2019 Aug;46:157-162.
• Menezes GLG, Mann RM, Meeuwis C, Bisschops B, Veltman J, Lavin PT, van de Vijver MJ, Pijnappel RM. Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkers. Eur Radiol. 2019 Dec;29(12):6728-6740.
• Ponti A, Ronco G, Lynge E, Tomatis M, Anttila A, Ascunce N, Broeders M, Bulliard JL, Castellano I, Fitzpatrick P, Frigerio A, Hofvind S, Májek O, Segnan N, Taplin S; ICSN DCIS Working Group. Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study. Breast Cancer Res Treat. 2019 Oct;177(3):761-765.
• Rainey L, Jervaeus A, Donnelly LS, Evans DG, Hammarström M, Hall P, Wengström Y, Broeders MJM, van der Waal D. Women’s perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study. Psychooncology. 2019 May;28(5):1056-1062.
• Rodríguez-Ruiz A, Krupinski E, Mordang JJ, Schilling K, Heywang-Köbrunner SH, Sechopoulos I, Mann RM. Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology. 2019 Feb;290(2):305-314.
• Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, Helbich TH, Chevalier M, Tan T, Mertelmeier T, Wallis MG, Andersson I, Zackrisson S, Mann RM, Sechopoulos I. Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists. J Natl Cancer Inst. 2019 Sep 1;111(9):916-922.
• Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Teuwen J, Broeders M, Gennaro G, Clauser P, Helbich TH, Chevalier M, Mertelmeier T, Wallis MG, Andersson I, Zackrisson S, Sechopoulos I, Mann RM. Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study. Eur Radiol. 2019 Sep;29(9):4825-4832.
• Sanderink WBG, Laarhuis BI, Strobbe LJA, Sechopoulos I, Bult P, Karssemeijer N, Mann RM. A systematic review on the use of the breast lesion excision system in breast disease. Insights Imaging. 2019 May 2;10(1):49.
• Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C, Follmann M, Mansel R, Sardanelli F, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Warman S, Saz Parkinson Z; European Commission Initiative on Breast Cancer Contributor Group. Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency. Ann Intern Med. 2019 Jul 23. doi: 10.7326/M18-3445. [Epub ahead of print]
• van Geel K, Kok EM, Krol JP, Houben IPL, Thibault FE, Pijnappel RM, van Merriënboer JJG, Lobbes MBI. Reversal of the hanging protocol of Contrast Enhanced Mammography leads to similar diagnostic performance yet decreased reading times. Eur J Radiol. 2019 Aug;117:62-68.
• Vreemann S, Dalmis MU, Bult P, Karssemeijer N, Broeders MJM, Gubern-Mérida A, Mann RM. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: A retrospective cohort study. Eur Radiol. 2019 Sep;29(9):4678-4690.